Revelation Biosciences In...

2.60
-0.03 (-1.14%)
At close: Apr 01, 2025, 3:51 PM
2.63
1.18%
After-hours: Apr 01, 2025, 07:45 PM EDT

Revelation Biosciences Statistics

Share Statistics

Revelation Biosciences has 905.23K shares outstanding. The number of shares has increased by 779.93% in one year.

Shares Outstanding 905.23K
Shares Change (YoY) 779.93%
Shares Change (QoQ) 71.95%
Owned by Institutions (%) 0.3%
Shares Floating 904.92K
Failed to Deliver (FTD) Shares 680
FTD / Avg. Volume 0.28%

Short Selling Information

The latest short interest is 45.86K, so 8.78% of the outstanding shares have been sold short.

Short Interest 45.86K
Short % of Shares Out 8.78%
Short % of Float 8.78%
Short Ratio (days to cover) 0.11

Valuation Ratios

The PE ratio is undefined and the forward PE ratio is -0.13. Revelation Biosciences's PEG ratio is undefined.

PE Ratio undefined
Forward PE -0.13
PS Ratio 0
Forward PS 0
PB Ratio 0
P/FCF Ratio undefined
PEG Ratio undefined
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Revelation Biosciences Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3430.96, with a Debt / Equity ratio of undefined.

Current Ratio 3430.96
Quick Ratio 3430.96
Debt / Equity undefined
Total Debt / Capitalization -
Cash Flow / Debt null
Interest Coverage undefined

Financial Efficiency

Return on equity (ROE) is null% and return on capital (ROIC) is -169.38%.

Return on Equity (ROE) null%
Return on Assets (ROA) null%
Return on Capital (ROIC) -169.38%
Revenue Per Employee $0
Profits Per Employee $-1,879,817,000
Employee Count 8
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -93.73% in the last 52 weeks. The beta is 0.18, so Revelation Biosciences's price volatility has been higher than the market average.

Beta 0.18
52-Week Price Change -93.73%
50-Day Moving Average 3.74
200-Day Moving Average 13.27
Relative Strength Index (RSI) 29.07
Average Volume (20 Days) 242.9K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -7.98B
Net Income -15.04B
EBITDA -7.98B
EBIT n/a
Earnings Per Share (EPS) -8768.31
Full Income Statement

Balance Sheet

The company has 6.5M in cash and 0 in debt, giving a net cash position of 6.5M.

Cash & Cash Equivalents 6.5M
Total Debt 0
Net Cash 6.5M
Retained Earnings -40.51B
Total Assets 6.62B
Working Capital 6.56B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.32B and capital expenditures -19.17K, giving a free cash flow of -18.34B.

Operating Cash Flow -18.32B
Capital Expenditures -19.17K
Free Cash Flow -18.34B
FCF Per Share -10693.51
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

REVB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -337242.69%
FCF Yield -779253.12%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for REVB.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Jan 28, 2025. It was a backward split with a ratio of 1:16.

Last Split Date Jan 28, 2025
Split Type backward
Split Ratio 1:16

Scores

Altman Z-Score -7.38
Piotroski F-Score 1